Publications and media
BioWorld MedTech, April 22, 2021
Annette Boyle: atHeart Medical begins IDE trial for septal closure device
Read more...
Diagnostic and Interventional Cardiology, April 20, 2021
Bioresorbable ASD Occluder Prepares to Enter U.S. Clinical Trial
Read more...
Cardiac Interventions Today, April 20, 2021
atHeart Medical Commences Operations and Prepares Pivotal Trial of reSept ASD Occluder
Read more...
March 1, 2021
reSept ASD Occluder by atHeart Medical: atHeart Medical aims to establish the first and only transcatheter ASD occluder with a metal-free frame as a new standard of care for atrial septal defects (ASDs).
Read more...
Gsundheit! 37. Baarer Heimatbuch 2019/2020
Cluster machen Unternehmen erfolgreicher - Pharma- und Medtech-Firmen in Baar
Read more...
CONTACT
CARAG AG Bahnhofstrasse 9 6340 Baar Switzerland
T +41 41 766 02 02 F +41 41 766 02 00 info@carag.com